News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,467 Results
Type
Article (43243)
Company Profile (275)
Press Release (661949)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (205475)
Career Advice (2021)
Deals (35552)
Drug Delivery (97)
Drug Development (81641)
Employer Resources (173)
FDA (16270)
Job Trends (14947)
News (347330)
Policy (32777)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2634)
Accelerated approval (6)
Adcomms (23)
Allergies (83)
Alliances (49897)
ALS (89)
Alzheimer's disease (1379)
Antibody-drug conjugate (ADC) (117)
Approvals (16264)
Artificial intelligence (245)
Autoimmune disease (21)
Automation (15)
Bankruptcy (363)
Best Places to Work (11723)
BIOSECURE Act (20)
Biosimilars (104)
Biotechnology (200)
Bladder cancer (64)
Brain cancer (27)
Breast cancer (270)
Cancer (2144)
Cardiovascular disease (171)
Career advice (1685)
Career pathing (29)
CAR-T (148)
Cell therapy (415)
Cervical cancer (19)
Clinical research (66261)
Collaboration (819)
Compensation (520)
Complete response letters (21)
COVID-19 (2620)
CRISPR (40)
C-suite (232)
Cystic fibrosis (101)
Data (2085)
Decentralized trials (2)
Denatured (17)
Depression (42)
Diabetes (260)
Diagnostics (6424)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (121)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (92)
Earnings (86675)
Editorial (35)
Employer branding (21)
Employer resources (147)
Events (112920)
Executive appointments (710)
FDA (17479)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (733)
Gene editing (106)
Generative AI (20)
Gene therapy (302)
GLP-1 (709)
Government (4440)
Grass and pollen (5)
Guidances (51)
Healthcare (18931)
Huntington's disease (23)
IgA nephropathy (24)
Immunology and inflammation (112)
Indications (27)
Infectious disease (2761)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (91)
Interviews (315)
IPO (16560)
IRA (40)
Job creations (3652)
Job search strategy (1433)
Kidney cancer (9)
Labor market (36)
Layoffs (469)
Leadership (16)
Legal (7963)
Liver cancer (74)
Lung cancer (310)
Lymphoma (144)
Machine learning (5)
Management (58)
Manufacturing (290)
MASH (64)
Medical device (13362)
Medtech (13367)
Mergers & acquisitions (19512)
Metabolic disorders (669)
Multiple sclerosis (76)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1897)
NextGen: Class of 2025 (6582)
Non-profit (4544)
Northern California (2577)
Now hiring (38)
Obesity (361)
Opinion (209)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (227)
Patient recruitment (103)
Peanut (46)
People (57657)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20689)
Phase II (29161)
Phase III (21733)
Pipeline (1125)
Policy (133)
Postmarket research (2584)
Preclinical (8803)
Press Release (67)
Prostate cancer (100)
Psychedelics (31)
Radiopharmaceuticals (246)
Rare diseases (389)
Real estate (5946)
Recruiting (65)
Regulatory (22405)
Reports (46)
Research institute (2420)
Resumes & cover letters (352)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (67)
Series A (129)
Series B (82)
Service/supplier (12)
Sickle cell disease (55)
Southern California (2214)
Special edition (15)
Spinal muscular atrophy (158)
Sponsored (28)
Startups (3626)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (29)
The Weekly (30)
United States (22411)
Vaccines (683)
Venture capitalists (40)
Weight loss (233)
Women's health (34)
Worklife (15)
Date
Today (179)
Last 7 days (506)
Last 30 days (2446)
Last 365 days (33096)
2025 (9639)
2024 (35480)
2023 (40319)
2022 (51526)
2021 (56037)
2020 (54397)
2019 (46868)
2018 (35298)
2017 (32458)
2016 (31917)
2015 (37926)
2014 (31652)
2013 (26838)
2012 (29017)
2011 (29667)
2010 (27744)
Location
Africa (743)
Alabama (52)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (38284)
Australia (6304)
California (5899)
Canada (1959)
China (496)
Colorado (258)
Connecticut (270)
Delaware (136)
Europe (82698)
Florida (871)
Georgia (202)
Idaho (57)
Illinois (518)
India (25)
Indiana (304)
Iowa (10)
Japan (154)
Kansas (102)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (871)
Massachusetts (4421)
Michigan (216)
Minnesota (382)
Mississippi (2)
Missouri (80)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (63)
New Jersey (1674)
New Mexico (28)
New York (1686)
North Carolina (959)
North Dakota (7)
Northern California (2577)
Ohio (198)
Oklahoma (14)
Oregon (33)
Pennsylvania (1328)
Puerto Rico (11)
Rhode Island (32)
South America (1118)
South Carolina (21)
South Dakota (1)
Southern California (2214)
Tennessee (100)
Texas (877)
Utah (173)
Virginia (139)
Washington D.C. (60)
Washington State (554)
West Virginia (3)
Wisconsin (51)
705,467 Results for "atossa genetics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nona Biosciences and Atossa Therapeutics Partner to Discover Next-Generation Antibody Therapies for Breast Cancer
April 10, 2025
·
2 min read
Business
Societal CDMO Enters Agreement With Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator
Societal CDMO, Inc. today announced that it has been selected by Atossa Therapeutics (Nasdaq: ATOS ) to provide a range of its Clinical Trial Services (CTS) offerings focused on Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen.
May 23, 2023
·
5 min read
Business
Atossa Therapeutics and Quantum Leap Healthcare Provide Enrollment Update for (Z)-Endoxifen Arm of Ongoing I-SPY 2 Clinical Trial
Atossa Therapeutics, Inc. and Quantum Leap Healthcare Collaborative™ (“Quantum Leap”) today announced that six patients have been dosed with Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, in the ongoing Phase 2 I-SPY 2 clinical trial.
June 28, 2023
·
6 min read
Press Releases
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
March 20, 2025
·
8 min read
Gene therapy
Regeneron’s Gene Therapy Restores Hearing in Patients with Rare Genetic Condition
The treatment, called DB-OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic deafness.
February 24, 2025
·
4 min read
·
Dan Samorodnitsky
Press Releases
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
February 7, 2025
·
10 min read
Press Releases
Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting
March 11, 2025
·
3 min read
BioForest
Atossa Therapeutics and Quantum Leap Healthcare Announce New Study Arm to Evaluate (Z)-Endoxifen in the Ongoing I-SPY 2 Clinical Trial
Atossa Therapeutics, Inc. (Nasdaq: ATOS) and Quantum Leap Healthcare Collaborative™ today announce that Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, will be evaluated in a new study arm of the ongoing I-SPY 2 clinical trial.
March 21, 2023
·
8 min read
Press Releases
Baylor Genetics Presents New Data on Genetic and Functional Testing to Diagnose Mitochondrial Disorders at 2025 ACMG Annual Clinical Genetics Meeting
March 21, 2025
·
3 min read
Press Releases
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
February 28, 2025
·
3 min read
1 of 70,547
Next
